Lei Chang, Qu Diyang, Chong Dennis, Yi Yangyang, Wu Weijian, Tu Yiheng, Chen Runsen
Vanke School of Public Health, Tsinghua University, Beijing, China.
CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China.
Gen Psychiatr. 2025 Jun 27;38(3):e102077. doi: 10.1136/gpsych-2025-102077. eCollection 2025.
BACKGROUND: Pain sensitivity is critical for preventing non-suicidal self-injury (NSSI) behaviours; however, individuals engaging in such behaviours often exhibit decreased pain sensitivity, which may undermine this natural safeguard. The dorsolateral prefrontal cortex (DLPFC) is a key region involved in pain regulation, and recent approaches using transcranial direct current stimulation (tDCS) to target the DLPFC have shown potential for modulating pain processing and restoring normal pain perception for individuals engaging in NSSI behaviours. AIMS: This study aimed to explore the immediate and short-term effects of a single session of tDCS on pain sensitivity in individuals with NSSI, as well as its secondary effects on mood and NSSI-related factors. METHODS: In this randomised, double-blind, parallel, sham-controlled clinical trial, participants with a history of NSSI were randomly assigned to receive either active or sham tDCS. The intervention consisted of a single 20 min tDCS session targeting the left DLPFC. The primary outcome was pain sensitivity, measured by the pressure pain threshold (PPT) and heat pain score (HPS). Secondary and additional outcomes included NSSI urges, NSSI resistance, self-efficacy in resisting NSSI, mood-related variables and exploratory cognitive-affective processes such as rumination, self-criticism and self-perceived pain sensitivity, assessed at baseline, immediately post-intervention, and at 24 hours, 1 week and 2 weeks follow-ups. RESULTS: For the primary outcomes, no significant differences between groups were observed for pain sensitivity (PPT, p=0.812; HPS, p=0.608). However, an exploratory sensitivity analysis treating each trial as an individual observation revealed a significant effect on HPS (p=0.036). For the secondary and additional outcomes, although there were initial improvements in joyful feelings and reductions in negative affect at 2 weeks post-intervention, these effects did not remain significant after multiple comparison corrections. Notably, reductions in rumination were statistically significant at both 1-week and 2-week follow-ups (1 week, p=0.040; 2 weeks, p=0.042). There were no significant effects on NSSI urges, NSSI resistance, self-efficacy in resisting NSSI or self-criticism. CONCLUSIONS: A single session of tDCS over the left DLPFC did not produce significant changes in pain sensitivity in individuals with NSSI. A sensitivity analysis indicated an effect on heat pain sensitivity, possibly reflecting changes in brain activity, warranting confirmation through neuroimaging. These findings suggest that tDCS warrants further investigation for its potential to influence pain-related cognitive-affective processes in individuals with NSSI.
背景:疼痛敏感性对于预防非自杀性自伤(NSSI)行为至关重要;然而,从事此类行为的个体往往表现出疼痛敏感性降低,这可能会破坏这种天然的保护机制。背外侧前额叶皮层(DLPFC)是参与疼痛调节的关键区域,最近使用经颅直流电刺激(tDCS)靶向DLPFC的方法已显示出调节疼痛处理并恢复从事NSSI行为个体的正常疼痛感知的潜力。 目的:本研究旨在探讨单次tDCS对NSSI个体疼痛敏感性的即时和短期影响,以及对情绪和NSSI相关因素的次要影响。 方法:在这项随机、双盲、平行、假对照临床试验中,有NSSI病史的参与者被随机分配接受活性或假tDCS。干预包括针对左侧DLPFC的单次20分钟tDCS治疗。主要结局是疼痛敏感性,通过压力疼痛阈值(PPT)和热痛评分(HPS)来衡量。次要和附加结局包括NSSI冲动、NSSI抵抗力、抵抗NSSI的自我效能感、情绪相关变量以及探索性认知情感过程,如沉思、自我批评和自我感知的疼痛敏感性,在基线、干预后即刻、24小时、1周和2周随访时进行评估。 结果:对于主要结局,两组在疼痛敏感性方面未观察到显著差异(PPT,p = 0.812;HPS,p = 0.608)。然而,将每个试验视为个体观察的探索性敏感性分析显示对HPS有显著影响(p = 0.036)。对于次要和附加结局,尽管干预后2周时愉悦感最初有所改善,负面影响有所减少,但在多次比较校正后这些影响不再显著。值得注意的是,在1周和2周随访时沉思的减少在统计学上均显著(1周,p = 0.040;2周,p = 0.042)。对NSSI冲动、NSSI抵抗力、抵抗NSSI的自我效能感或自我批评没有显著影响。 结论:对左侧DLPFC进行单次tDCS治疗并未使NSSI个体的疼痛敏感性产生显著变化。敏感性分析表明对热痛敏感性有影响,可能反映了大脑活动的变化,需要通过神经影像学进行确认。这些发现表明,tDCS因其影响NSSI个体疼痛相关认知情感过程的潜力而值得进一步研究。
Cochrane Database Syst Rev. 2018-3-16
Cochrane Database Syst Rev. 2018-4-13
Cochrane Database Syst Rev. 2023-10-9
Cochrane Database Syst Rev. 2016-8-22
Cochrane Database Syst Rev. 2016-4-4
Cochrane Database Syst Rev. 2018-3-1
Sci Bull (Beijing). 2024-12-30
Cell Rep Med. 2024-10-15
Clin Neurophysiol. 2024-10
J Pharmacol Exp Ther. 2024-5-21
Lancet Reg Health West Pac. 2023-5-26
Front Pain Res (Lausanne). 2022-9-15